New Triple-Drug cocktail targets untreated follicular lymphoma
NCT ID NCT07585747
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests a combination of three drugs (orelabrutinib, tafasitamab, and lenalidomide) as a first treatment for people with follicular lymphoma, a slow-growing blood cancer. About 27 newly diagnosed adults will receive the drugs to see how well they shrink tumors and control the disease. The goal is to improve response rates while monitoring safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan Cancer Hospital
Zhengzhou, Henan, 450000, China
-
Institute of Hematology & Blood Diseases Hospital, China
Tianjin, Tianjin Municipality, 300020, China
-
Qilu Hospital of Shandong Province
Jinan, Shandong, China
Contact Phone: •••-•••-••••
-
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
Contact Phone: •••-•••-••••
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330000, China
Conditions
Explore the condition pages connected to this study.